Stem Cell Therapy Market Research Report, by Type (Allogeneic, Autologous), by Product Type (Antibodies, Kits), by Application (Clinical Research), & by End-User (Clinical Diagnostics, Hospitals & Research Institutes) – Global Forecast Till 2023
Market Highlights
The global stem cell therapy market is expected to witness tremendous growth owing to the rising prevalence of cancer, heart diseases, stroke, and osteoarthritis. Other key factors such as the change to sedentary lifestyle, growing consumption of alcohol, and an increase in smoking are contributing towards the growth of the market. However, factors such as high cost of surgical procedures, expensive chemotherapy treatments, the risk of rejecting cells by patient’s body as the cells are derived from embryos these factors can restrict the market growth during the forecast period.
Segmentation
- The global stem cell therapy market is segmented on the basis of type, therapeutic application, cell source, and end user. The stem cell therapy market, by type, is sub-segmented into Allogeneic and Autologous. On the basis of therapeutic application, the market is categorized into medicine, cardiovascular diseases, bone regeneration, neurodegenerative disorders, wound healing, treatment of eyes, hematopoietic disorders, metabolic disorders, cancer, immunodeficiency, and diabetes. Cell source is further sub-segmented into adipose tissue, bone marrow, neural, embryo/cord blood-derived, iPSCs. On the basis of end-user, the market is segmented into biotechnology companies, hospitals & research institutes, contract research organizations and stem cell banks.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6422
Regional Analysis
The Americas is the largest in the market owing to the increasing prevalence of heart diseases and growing healthcare expenditure. According to the Centers for Disease Control and Prevention in November 2017, report every year 735,000 Americans have a heart problem. Such a high number of heart patients in the Americas drives the market growth in this region.
Europe (UK, Belgium, France, and Netherlands) is the second largest global stem cell therapy market during the forecast period. The increasing occurrence of stroke, cancer, and osteoarthritis drives the market in this region. According to Anthony Nolan organization 2017, annual review 1.4million people register for donating stem cell in 2017. Also, more than 2,200 searches for a lifesaving stem cell transplant were made in 2017 by UK people. Such a high demand for Stem cell transplantation in this region promotes the market.
Asia-Pacific was projected to be the fastest growing region for the global stem cell therapy market in 2017. The market is expected to witness growth owing to the rising prevalence of smoking in this region.
According to the American Cancer Society, Inc 2018, report China 48.9%, India 16.2%, Japan 11.2% accounts of cancer cases in this region. Such a high cancer rate in this region favors the stem cell therapy market in this region.
The Middle East and Africa accounts for the least share due to low per capita income and lack of availability of well-trained healthcare professionals. However, the rising oncology and technology both at the hospital level and in the community are expected to influence the market in a positive way.
Key Players
Some of the key players are Osiris Therapeutics, Inc. (US), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (US), RTI Surgical, Inc. (US), and AlloSource (US), and Thermo Fisher Scientific Inc
Browse Detailed TOC with COVID-19 Impact Analysis @ https://www.marketresearchfuture.com/reports/stem-cell-therapy-market-6422
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reportsThe Stem Cell Global Market Report 2020-30 by The Business Research Company describes and explains the global stem cell market and covers 2015 to 2020, termed the historic period, and 2020 to 2025, termed the forecast period, along with further forecasts for the period 2025-2030.
The report evaluates the market across each region and for the major economies within each region.The Stem Cell Global Market Report 2021 covers stem cell market drivers, stem cell market trends, stem cell market segments, stem cell market growth rate, stem cell market major players, and stem cell market size.View Complete Report: https://www.thebusinessresearchcompany.com/report/stem-cell-global-market-report The stem cell market report provides an in-depth analysis of the impact of COVID-19 on the global stem cell industry, along with revised market numbers due to the effects of the coronavirus and the expected stem cell market growth numbers 2021-2030.Stem Cell Global Market Report 2021 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.Request For The Sample Now: https://www.thebusinessresearchcompany.com/sample.aspx?id=2584=smpThe global stem cell market is expected to grow from $20.59 billion in 2020 to $22.87 billion in 2021 at a compound annual growth rate (CAGR) of 11.1%.
The stem cell market is expected to reach $36 billion in 2025 at a CAGR of 12%.The report covers the stem cell market segments-1) By Source: Autologous, Allogeneic.2) By Product Type: Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, Others.3) By Application: Regenerative Medicine, Drug Discovery And Development.About The Business Research Company: The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research.
It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally.
